Cell chemical biology · 2023
Identification of triazenyl indoles as inhibitors of fungal fatty acid biosynthesis with broad-spectrum activity.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iyer Kali R, Li Sheena C, Revie Nicole M, Lou Jennifer W, Duncan Dustin, Fallah Sara, Sanchez Hiram, Skulska Iwona, Ušaj Mojca Mattiazzi, Safizadeh Hamid, Larsen Brett, Wong Cassandra, Aman Ahmed, Kiyota Taira, Yoshimura Mami, Kimura Hiromi, Hirano Hiroyuki, Yoshida Minoru, Osada Hiroyuki, Gingras Anne-Claude, Andes David R, Shapiro Rebecca S, Robbins Nicole, Mazhab-Jafari Mohammad T, Whitesell Luke, Yashiroda Yoko, Boone Charles, Cowen Leah E
Аннотация
Rising drug resistance among pathogenic fungi, paired with a limited antifungal arsenal, poses an increasing threat to human health. To identify antifungal compounds, we screened the RIKEN natural product depository against representative isolates of four major human fungal pathogens. This screen identified NPD6433, a triazenyl indole with broad-spectrum activity against all screening strains, as well as the filamentous mold Aspergillus fumigatus. Mechanistic studies indicated that NPD6433 targets the enoyl reductase domain of fatty acid synthase 1 (Fas1), covalently inhibiting its flavin mononucleotide-dependent NADPH-oxidation activity and arresting essential fatty acid biosynthesis. Robust Fas1 inhibition kills Candida albicans, while sublethal inhibition impairs diverse virulence traits. At well-tolerated exposures, NPD6433 extended the lifespan of nematodes infected with azole-resistant C. albicans. Overall, identification of NPD6433 provides a tool with which to explore lipid homeostasis as a therapeutic target in pathogenic fungi and reveals a mechanism by which Fas1 function can be inhibited.